FUJIFILM Corp. engages in the provision of imaging and information solutions. Its offers photography equipment, supplies and services, optical devices, healthcare, high-performance materials, graphic systems, recording media, and industrial products. The company was founded on October 2, 2006 and is headquartered in Tokyo, Japan.

Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI.

Hitachi Aloka Medical Ltd. engages in the manufacture and sale of medical electronic, general and medical analysis systems. It also provides the development of nuclear diagnostic, osteoporosis diagnostic, sample testing, therapeutic and surgical systems. The company was founded on January 20, 1950 and is headquartered in Tokyo, Japan.

Jiangsu Xuzhou Pinyuan Electronic Technology Co., Ltd., a high-tech enterprise in Jiangsu Province, is located in the high-speed railway business zone of Xuzhou Economic and Technological Development Zone, a development zone. It is a manufacturer specializing in the research, development, production and sales of medical equipment and medical teaching equipment. Relying on the company's advantages in research, development, production and sales of medical equipment for many years, as well as more than 20 years of experience in the medical equipment industry and nearly 10 years of experience in teaching equipment, The company has organized a group of experienced technicians to be close to the front line of customers, and has developed a number of medical equipment and medical teaching equipment, which have been used by customers, and has won a lot of praise and good reputation. The company's products mainly include three series of nearly 20 varieties, BMD-A series ultrasonic bone mineral density detector products, BMD-Q series wireless ultrasonic bone mineral density detector products, and medical teaching equipment series products. Among them, BMD-A series ultrasonic bone mineral density detector products have passed the electromagnetic compatibility EMC testing products among domestic peers, indicating that the quality of the company's products reaches the quality level of EU products; BMD-Q series wireless ultrasonic bone density detector is a national patent product. At present, the company's products have been sold to medical institutions and high efficiency in more than 20 provinces nationwide, and have been widely recognized by application customers. At the same time, the company also cooperates effectively with many research institutions such as the Chinese Academy of Sciences, Tianjin University, Nanjing University of Aeronautics and Astronautics, and conducts product development in a complementary way.

Tianjin Development Zone Shenghong Medical Equipment Co., Ltd., established on 1996-10-14, Business scope includesIIkind6830medicalXX-ray equipment(Bone Densitometry Bone Age Meter),Production,Sales and development of related technology products,transfer,Technical Services;Business,Wholesale and retail of material supply and marketing;technology development,transfer;Medical device related intermediary,consultation service(Involving industry management certificate management);Software development and product sales;Wholesale and retail of computer software;Machinery and Equipment Leasing(Except finance lease).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Demetech develops, manufactures and markets systems for the diagnosis and early detection of osteoporosis.

UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain

Osstem develops and produces dental implants for dental treatment featuring dental equipment. They develop 3D printing and milling materials which are core materials of digital dentistry and repair materials. They provide total solutions for dental treatment featuring dental equipment, materials, and pharmaceutical products. Their development and sales of medical equipment including unit chairs, CTS, and panorama imaging devices.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Nihon Medi-Physics Co., Ltd. is a Japanese joint venture company located in Koto-ku focused on pharmaceutical preparations. The firm was founded in 1973. Nobuhiko Tamura is the current CEO of the company.\nThe company says this about itself: Nihon Medi-Physics is engaging in ensuring stable supply and research and development of the products as a leading manufacturer of radiopharmaceuticals in Japan. Based on the technological proficiency and trust built over the years, the company is also working on research and development of \"Theranostics (a combination of therapy and diagnosis),\" which is a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. The company will continue contributing to society by creating values as a life science company.

LargeV develops and industrializes high-end medical devices. The core team of LargeV was from Tsinghua University and has solid foundation in the technical fields of CT imaging, radiation protection, image processing and etc. It was founded in 2011and is based in Haidian District, Beijing, China.

GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

SELVAS Healthcare, Inc. engages in the manufacturing and distributing of medical equipment. It operates through the Medical Analytical Equipment and Assistive Technology Equipment Businesses. The Medical Analytical Equipment Business provides body composition analyzers and automatic blood pressure analyzers. The Assistive Technology Equipment Business provides book reading equipment, magnifiers, and braille information instrument. The company was founded on January 21, 1999 and is headquartered in Daejeon, South Korea.

Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company’s proprietary Fc-fusion proteins and other engineered ligands which bind to specific Fc receptors. These technologies, including Syntonix’ drug delivery platform technology Transceptor™, harness the body’s natural pathways for protecting antibodies against premature destruction and for transporting antibodies across cell barriers such as those in the lungs and intestines. Syntonix focuses on using these technologies to create next generation treatments for devastating chronic diseases such as hemophilia, anemia, and autoimmune disorders. Syntonix develops selected products for specialty indications, such as hemophilia, on its own. Other products will be evaluated and commercialized through partnerships with companies with established market positions. The company is headed by an experienced management team and has focused initially on using its proprietary technology to enhance existing drugs with proven safety, efficacy, and economic return. Syntonix currently occupies a 25,000 square foot state-of-the-art laboratory facility, including a cGMP clinical manufacturing suite, in Waltham, Massachusetts.

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Bohr (Suzhou) Electronic Technology Co., Ltd., established on 2020-03-16, Business scope includes general items:software development;IoT Device Sales;Internet of Things Technology Services;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Machinery sales;Sales of electrical instruments and meters;electronics sales;Industrial automatic control system device sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Daily miscellaneous goods sales;Household Appliances Retail;Household Appliances Wholesale;Wholesale of electronic components(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)